Functional characterization of somatic point mutations of the human estrogen receptor α (hERα) in adenomyosis uteri
Authors:
- Holger GreschikHGHolger Greschik
- Dagmar-C. FischerDFDagmar-C. Fischer
- Xiaowen TongXTXiaowen Tong
- Roland SchueleRSRoland Schuele
- Dirk G. KiebackDKDirk G. Kieback
Open Access
- 1 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 10 (12) , 853-860
Abstract
Endometriosis and adenomyosis uteri are chronic, benign diseases caused by the presence of endometrial tissue in ectopic locations, e.g. peritoneal or deep inside the myometrial wall of the uterus and/or in the rectovaginal septum. Although adenomyosis might be considered as a special form of endometriosis, both conditions differ with respect to clinical symptoms and treatment. Induction of a hypo-estrogenic state alone or in combination with surgical removal of the extra-uterine lesion is mostly sufficient for treatment of peritoneal endometriosis. By contrast, adenomyosis uteri rarely responds to hormonal therapy and usually requires a hysterectomy for cure. Consequently, the role of steroid hormone receptors with respect to the aetiology of either condition is still a matter of discussion. Using PCR/single strand conformation polymorphism analysis, we identified somatic estrogen receptor (ER) α gene mutations in three out of 55 samples from adenomyosis uteri. Functional characterization revealed that two of the mutant ERα proteins display severely impaired DNA-binding and transactivation properties secondary to an altered response to estrogens or changes in epidermal growth factor-mediated ligand-independent activation. Although the exact mechanism remains unknown, we suggest that mutation-related silencing of estrogen responsiveness might render endometriotic cells resistant to hypo-estrogenic conditions thereby accounting for failure of estrogen-ablative therapy in adenomyosis.Keywords
This publication has 41 references indexed in Scilit:
- Allosteric Control of Ligand Selectivity between Estrogen Receptors α and βMolecular Cell, 2004
- Binding of Ligands and Activation of Transcription by Nuclear ReceptorsAnnual Review of Biophysics, 2001
- Analysis of Mechanisms That Determine Dominant Negative Estrogen Receptor EffectivenessJournal of Biological Chemistry, 1995
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995
- SETOR: Hardware-lighted three-dimensional solid model representations of macromoleculesJournal of Molecular Graphics, 1993
- Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniquesHuman Mutation, 1993
- Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptorsCell, 1991
- Improved methods for building protein models in electron density maps and the location of errors in these modelsActa Crystallographica Section A Foundations of Crystallography, 1991
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- Gene regulation by steroid hormonesCell, 1989